Clinical Trial Update: Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia [Phase 4]

View source ↗

Summary

Phase 4 study assessing the safety and efficacy of Desferasirox in Chinese patients with iron overload and aplastic anemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aplastic Anemia
• Iron Overload

Drugs mentioned

• Desferasirox (desferasirox)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Iron Overload | Phase 4 | Status: COMPLETED